Immunosenescence in radio-immunotherapy: From biological mechanisms to therapeutic opportunities?
Ageing Research Reviews · 2027-01 · 123 · 103434
DOI: 10.1016/j.arr.2026.103434 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2027-01. Verfasst von Shaochuan Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China; Tianjin's Clinical Res…. Die Arbeit nennt 365 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Radiotherapy combined with immunotherapy has emerged as a promising therapeutic strategy across multiple cancer types. However, despite encouraging findings from selected clinical trials, most radioimmunotherapy studies have shown only limited or even negative results, highlighting important biological barriers that limit therapeutic efficacy. Accumulating evidence suggests that radiotherapy induces phenotypic and functional changes in immune cells that resemble key features of age-related immunosenescence, including thymic involution, persistent low-grade inflammation, impaired immune reconstitution, and the accumulation of senescent cells. In this review, we systematically characterize this radiation-induced immunosenescence and distinguish it from physiological immunosenescence. We further introduce the concept of "radiation-induced immunosenescence mimicry," which we propose that this mimicry may represent a critical and previously underappreciated obstacle limiting the efficacy of current radioimmunotherapy. We summarize current evidence describing the impact of radiotherapy on immunosenescence and propose a stratification framework based on baseline immune reserve, radiation field and dose, lymphoid organ exposure, and other clinically relevant variables. Building on this framework, we discuss emerging strategies designed to target radiation-induced immunosenescence mimicry in combination with immunotherapy, together with relevant clinical investigations. Finally, we propose personalized diagnostic and therapeutic approaches for the future clinical integration of radiotherapy and immunotherapy, with the aim of overcoming the current dilemma of combined radioimmunotherapy and improving patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China; Key Laboratory of Canc…
- Metrowest Medical Center, Framingham, Massachusetts, MA 01702, USA.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, S., Li, L., Zhang, D., Yin, Z., Guan, Y., & Yuan, Z. (2027). Immunosenescence in radio-immunotherapy: From biological mechanisms to therapeutic opportunities?. Ageing Research Reviews, 123, 103434. https://doi.org/10.1016/j.arr.2026.103434
Vancouver
Liu S, Li L, Zhang D, Yin Z, Guan Y, Yuan Z. Immunosenescence in radio-immunotherapy: From biological mechanisms to therapeutic opportunities?. Ageing Research Reviews. 2027;123:103434. doi:10.1016/j.arr.2026.103434
BibTeX
@article{Liu2027,
author = {Liu, Shaochuan and Li, Liuze and Zhang, Deyi and Yin, Zhenzhen and Guan, Yong and Yuan, Zhiyong},
title = {Immunosenescence in radio-immunotherapy: From biological mechanisms to therapeutic opportunities?},
journal = {Ageing Research Reviews},
year = {2027},
volume = {123},
pages = {103434},
doi = {10.1016/j.arr.2026.103434}
}
EUVIMED